FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
Jennifer Abbasi
Abstract
This Medical News article discusses the November 8 US Food and Drug Administration approval of the drug tirzepatide for chronic weight management in people with obesity or overweight with weight-related conditions.
Topics & Concepts
MedicineFood and drug administrationOverweightWeight managementObesityManagement of obesityDrugBody weightWeight lossDrug administrationFamily medicinePharmacologyInternal medicinePharmacology and Obesity Treatment